Ledger.Open graph →
SEC Form D · filed May 20, 2020

Nivagen Pharmaceuticals, Inc

Offering
$16.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SACRAMENTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Richard Cohan · Greenville, INDirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorJwalant Shukla · Sacramento, CAExec · DirectorRob C. Hart · San Francisco, CADirectorJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorJwalant Shukla · Sacramento, CAExec · DirectorCliff R. Brokaw · CHEVY CHASE, MDDirectorDapeng Xu · New York, NYDirectorBikramjit Singh · Morganville, NJDirectorBikramjit Singh · Morganville, NJDirectorAshish C. Sevak · Paramus, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗